» Articles » PMID: 19828621

The Bovine Immunodeficiency Virus Rev Protein: Identification of a Novel Lentiviral Bipartite Nuclear Localization Signal Harboring an Atypical Spacer Sequence

Overview
Journal J Virol
Date 2009 Oct 16
PMID 19828621
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The bovine immunodeficiency virus (BIV) Rev protein (186 amino acids [aa] in length) is involved in the nuclear exportation of partially spliced and unspliced viral RNAs. Previous studies have shown that BIV Rev localizes in the nucleus and nucleolus of infected cells. Here we report the characterization of the nuclear/nucleolar localization signals (NLS/NoLS) of this protein. Through transfection of a series of deletion mutants of BIV Rev fused to enhanced green fluorescent protein and fluorescence microscopy analyses, we were able to map the NLS region between aa 71 and 110 of the protein. Remarkably, by conducting alanine substitution of basic residues within the aa 71 to 110 sequence, we demonstrated that the BIV Rev NLS is bipartite, maps to aa 71 to 74 and 95 to 101, and is predominantly composed of arginine residues. This is the first report of a bipartite Rev (or Rev-like) NLS in a lentivirus/retrovirus. Moreover, this NLS is atypical, as the length of the sequence between the motifs composing the bipartite NLS, e.g., the spacer sequence, is 20 aa. Further mutagenesis experiments also identified the NoLS region of BIV Rev. It localizes mainly within the NLS spacer sequence. In addition, the BIV Rev NoLS sequence differs from the consensus sequence reported for other viral and cellular nucleolar proteins. In summary, we conclude that the nucleolar and nuclear localizations of BIV Rev are mediated via novel NLS and NoLS motifs.

Citing Articles

Nuclear and Nucleolar Localization of Bovine Adenovirus-3 Protein V.

Zhao X, Tikoo S Front Microbiol. 2021; 11:579593.

PMID: 33488533 PMC: 7815533. DOI: 10.3389/fmicb.2020.579593.


Characterization of Signal Sequences Determining the Nuclear/Nucleolar Import and Nuclear Export of the Caprine Arthritis-Encephalitis Virus Rev Protein.

Labrecque M, Marchand C, Archambault D Viruses. 2020; 12(8).

PMID: 32824614 PMC: 7471974. DOI: 10.3390/v12080900.


The Jembrana disease virus Rev protein: Identification of nuclear and novel lentiviral nucleolar localization and nuclear export signals.

Marchand C, Lemay G, Archambault D PLoS One. 2019; 14(8):e0221505.

PMID: 31437223 PMC: 6706053. DOI: 10.1371/journal.pone.0221505.


ORF73 LANA homologs of RRV and MneRV2 contain an extended RGG/RG-rich nuclear and nucleolar localization signal that interacts directly with importin β1 for non-classical nuclear import.

Howard K, Cherezova L, DeMaster L, Rose T Virology. 2017; 511:152-164.

PMID: 28850829 PMC: 5929975. DOI: 10.1016/j.virol.2017.08.029.


Flagellin in fusion with human rotavirus structural proteins exerts an adjuvant effect when delivered with replicating but non-disseminating adenovectors through the intrarectal route.

Girard A, Roques E, Massie B, Archambault D Mol Biotechnol. 2013; 56(5):394-407.

PMID: 24271565 DOI: 10.1007/s12033-013-9723-z.


References
1.
Dundr M, Leno G, Hammarskjold M, Rekosh D, Olson M . The roles of nucleolar structure and function in the subcellular location of the HIV-1 Rev protein. J Cell Sci. 1995; 108 ( Pt 8):2811-23. DOI: 10.1242/jcs.108.8.2811. View

2.
Hatanaka M . Discovery of the nucleolar targeting signal. Bioessays. 1990; 12(3):143-8. DOI: 10.1002/bies.950120310. View

3.
Lange A, Mills R, Lange C, Stewart M, Devine S, Corbett A . Classical nuclear localization signals: definition, function, and interaction with importin alpha. J Biol Chem. 2006; 282(8):5101-5. PMC: 4502416. DOI: 10.1074/jbc.R600026200. View

4.
Robbins J, Dilworth S, Laskey R, Dingwall C . Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell. 1991; 64(3):615-23. DOI: 10.1016/0092-8674(91)90245-t. View

5.
Kjems J, Askjaer P . Rev protein and its cellular partners. Adv Pharmacol. 2000; 48:251-98. DOI: 10.1016/s1054-3589(00)48009-9. View